| Literature DB >> 24069437 |
Mark Minnery1, Carmen Contreras, Rosa Pérez, Ninfa Solórzano, Karen Tintaya, Judith Jimenez, Silvia Soto, Leonid Lecca.
Abstract
INTRODUCTION: Tuberculosis, reported as the second most common infectious cause of death worldwide, is a key mortality contributor in developing countries and globally. The disease is endemic in Peru and while relative success was achieved during the 1990s in its control, this slowed as new complications, such as multi drug resistant TB arose. Health centre workers participating in the national DOTS program, create the front-line TB work-force in Peru meaning their knowledge and attitudes about the disease are key in its control.Entities:
Mesh:
Year: 2013 PMID: 24069437 PMCID: PMC3777965 DOI: 10.1371/journal.pone.0075698
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Participant Demographics.
|
| N=301 | |
|---|---|---|
| N | % | |
|
| ||
| M | 68 | 22.59% |
| F | 233 | 77.41% |
|
| ||
| 20-25 | 12 | 3.99% |
| 26-30 | 23 | 7.64% |
| 31-35 | 31 | 10.30% |
| 36-40 | 52 | 17.28% |
| 41-45 | 57 | 18.94% |
| 46-50 | 51 | 16.94% |
| 51-55 | 45 | 14.95% |
| 56-60 | 15 | 4.98% |
| 60+ | 15 | 4.98% |
|
| ||
| Doctor | 48 | 15.82% |
| Nurse | 65 | 21.88% |
| Nurse Technician | 67 | 22.22% |
| Health Promoter | 43 | 13.80% |
| Other | 78 | 26.26% |
|
| ||
| Yes | 139 | 46.18% |
| No | 161 | 53.49% |
|
| ||
| Yes | 11 | 3.65% |
| No | 290 | 96.35% |
|
| ||
| Yes | 56 | 18.60% |
| No | 245 | 81.40% |
Knowledge Scores total and by profession.
|
| ||||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| What is the germ which causes tuberculosis | 298 (99.0) | 46 (97.9) | 65 (100) | 65 (97.0) | 40 (93.0) | 78 (100) |
| Is TB a transmittable disease? | 288 (95.7) | 43 (91.5) | 61 (93.8) | 64 (95.5) | 40 (93.0) | 76 (97.4) |
| How is TB transmitted? | 291 (96.7) | 45 (95.7) | 65 (100) | 63 (94.0) | 39 (90.7) | 75 (96.1) |
| Who has higher risk in developing the TB disease? | 177 (58.8) | 33 (70.2) | 41 (63) | 42 (62.7) | 18 (41.9) | 42 (53.8) |
| Do all people with the TB infection develop the TB disease? | 163 (54.2) | 39 (83.0) | 42 (64.6) | 23 (34.3) | 14 (32.6) | 45 (57.6) |
| What is the most common symptom of pulmonary (TB of the lungs) TB? | 228 (75.7) | 36 (76.6) | 54 (83) | 42 (62.7) | 26 (60.5) | 67 (85.8) |
| Which is the most effective tool in the diagnosis of pulmonary TB? | 73 (24.3) | 10 (21.3) | 13 (20) | 23 (34.3) | 9 (20.9) | 15 (19.2) |
| How many sputum samples are necessary for collection to diagnose TB? | 253 (84.1) | 35 (74.5) | 60 (92.3) | 58 (86.6) | 33 (76.7) | 67 (85.8) |
| Is it possible to cure TB? | 294 (97.7) | 46 (97.9) | 63 (96.9) | 65 (97.0) | 41 (95.3) | 75 (96.1) |
| How long (in months) is a complete treatment for pulmonary TB under the primary scheme? | 286 (95.0) | 46 (97.9) | 64 (98.4) | 64 (95.5) | 40 (93.0) | 72 (92.3) |
| How many drugs are used in the primary scheme for treatment of pulmonary TB? | 263 (87.4) | 45 (95.7) | 63 (96.9) | 62 (92.5) | 32 (74.4) | 61 (78.2) |
| What is Mult Drug Resistant TB (MDR-TB)? | 112 (37.2) | 19 (40.4) | 25 (38.4) | 27 (40.3) | 17 (39.5) | 24 (30.7) |
| What is the frequency for follow up sputum tests under the primary scheme for pulmonary TB? | 51 (16.9) | 3 (6.4) | 15 (23) | 17 (25.4) | 3 (7.0) | 9 (11.5) |
| What is the most effective form for evaluating the results of a complete treatment scheme? | 107 (35.5) | 14 (29.8) | 21 (32.3) | 30 (44.8) | 16 (37.2) | 25 (32) |
| What are the consequences of an incomplete or abandoned treatment? | 147 (48.8) | 29 (61.7) | 29 (44.6) | 24 (35.8) | 20 (46.5) | 43 (55.1) |
| Mean score | 10.1 +/- 1.7 | 10.4 +/- 1.4 | 10.4 +/- 1.5 | 10.1 +/- 1.7 | 9.5 +/- 1.8 | 9.9 +/- 1.8 |
Profession vs attitudes.
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
|
|
| 81.7% | 94.8% | 89.1% | 85.6% | 74.9% | 81.4% | 54.8% | 53.8% | 43.7% | 64.6% | 90.4% | |||||||||||
|
| 7.5% | 3.0% | 5.5% | 5.3% | 8.5% | 5.4% | 8.5% | 5.4% | 18.3% | 13.1% | 3.0% | ||||||||||||
|
| 10.5% | 2.2% | 4.8% | 8.8% | 15.5% | 13.1% | 36.4% | 40.5% | 37.7% | 21.8% | 6.6% | ||||||||||||
|
|
| 93.9% | 95.5% | 87.9% | 92.4% | 72.7% | 87.9% | 57.6% | 50.0% | 39.4% | 63.6% | 89.4% | |||||||||||
|
| 3.0% | 3.0% | 7.6% | 1.5% | 9.1% | 4.5% | 10.6% | 7.6% | 10.6% | 15.2% | 4.5% | ||||||||||||
|
| 3.0% | 1.5% | 4.5% | 4.5% | 15.2% | 7.6% | 30.3% | 42.4% | 48.5% | 21.2% | 6.1% | ||||||||||||
|
|
| 84.1% | 98.6% | 92.8% | 89.9% | 72.5% | 87.0% | 53.6% | 55.1% | 40.6% | 72.5% | 95.7% | |||||||||||
|
| 2.9% | 1.4% | 0.0% | 4.3% | 8.7% | 7.2% | 8.7% | 2.9% | 20.3% | 7.2% | 1.4% | ||||||||||||
|
| 13.0% | 0.0% | 5.8% | 5.8% | 18.8% | 5.8% | 37.7% | 42.0% | 39.1% | 18.8% | 2.9% | ||||||||||||
|
|
| 75.4% | 92.8% | 89.9% | 91.3% | 65.2% | 79.7% | 58.0% | 55.1% | 47.8% | 62.3% | 92.8% | |||||||||||
|
| 10.1% | 2.9% | 4.3% | 4.3% | 15.9% | 4.3% | 13.0% | 7.2% | 21.7% | 14.5% | 1.4% | ||||||||||||
|
| 13.0% | 4.3% | 4.3% | 4.3% | 18.8% | 15.9% | 29.0% | 37.7% | 30.4% | 23.2% | 5.8% | ||||||||||||
|
|
| 73.7% | 97.4% | 86.8% | 76.3% | 89.5% | 76.3% | 65.8% | 57.9% | 50.0% | 68.4% | 89.5% | |||||||||||
|
| 13.2% | 2.6% | 10.5% | 7.9% | 5.3% | 2.6% | 5.3% | 2.6% | 23.7% | 13.2% | 2.6% | ||||||||||||
|
| 13.2% | 0.0% | 2.6% | 15.8% | 2.6% | 21.1% | 28.9% | 39.5% | 26.3% | 18.4% | 7.9% | ||||||||||||
|
|
| 81.4% | 89.8% | 88.1% | 78.0% | 74.6% | 76.3% | 39.0% | 50.8% | 40.7% | 55.9% | 84.7% | |||||||||||
|
| 8.5% | 5.1% | 5.1% | 8.5% | 3.4% | 8.5% | 5.1% | 6.8% | 15.3% | 15.3% | 5.1% | ||||||||||||
|
| 10.2% | 5.1% | 6.8% | 13.6% | 22.0% | 15.3% | 55.9% | 40.7% | 44.1% | 27.1% | 10.2% | ||||||||||||
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||
|
|
| 97.7% | 99.2% | 89.4% | 95.6% | 100.0% | 99.4% | 94.7% | 78.2% | 82.0% | 93.8% | ||||||||||||
|
| 0.0% | 0.0% | 3.0% | 1.5% | 0.0% | 0.0% | 2.3% | 4.7% | 3.5% | 3.5% | |||||||||||||
|
| 2.3% | 0.0% | 7.6% | 2.3% | 0.0% | 0.6% | 2.7% | 15.0% | 13.2% | 2.4% | |||||||||||||
|
|
| 98.5% | 98.5% | 92.4% | 98.5% | 100.0% | 100.0% | 98.5% | 75.8% | 75.8% | 95.5% | ||||||||||||
|
| 0.0% | 0.0% | 0.0% | 1.5% | 0.0% | 0.0% | 1.5% | 3.0% | 3.0% | 1.5% | |||||||||||||
|
| 1.5% | 0.0% | 7.6% | 0.0% | 0.0% | 0.0% | 0.0% | 18.2% | 19.7% | 3.0% | |||||||||||||
|
|
| 97.1% | 100.0% | 94.2% | 97.1% | 100.0% | 98.6% | 100.0% | 69.6% | 79.7% | 94.2% | ||||||||||||
|
| 0.0% | 0.0% | 1.4% | 1.4% | 0.0% | 0.0% | 0.0% | 7.2% | 4.3% | 4.3% | |||||||||||||
|
| 2.9% | 0.0% | 4.3% | 0.0% | 0.0% | 1.4% | 0.0% | 21.7% | 14.5% | 0.0% | |||||||||||||
|
|
| 95.7% | 100.0% | 81.2% | 87.0% | 100.0% | 100.0% | 89.9% | 76.8% | 79.7% | 94.2% | ||||||||||||
|
| 0.0% | 0.0% | 5.8% | 4.3% | 0.0% | 0.0% | 1.4% | 7.2% | 4.3% | 2.9% | |||||||||||||
|
| 4.3% | 0.0% | 13.0% | 7.2% | 0.0% | 0.0% | 7.2% | 11.6% | 13.0% | 2.9% | |||||||||||||
|
|
| 97.4% | 97.4% | 89.5% | 97.4% | 100.0% | 100.0% | 92.1% | 84.2% | 86.8% | 92.1% | ||||||||||||
|
| 0.0% | 0.0% | 2.6% | 0.0% | 0.0% | 0.0% | 5.3% | 2.6% | 2.6% | 5.3% | |||||||||||||
|
| 2.6% | 0.0% | 7.9% | 2.6% | 0.0% | 0.0% | 2.6% | 13.2% | 10.5% | 2.6% | |||||||||||||
|
|
| 100.0% | 100.0% | 89.8% | 98.3% | 100.0% | 98.3% | 93.2% | 84.7% | 88.1% | 93.2% | ||||||||||||
|
| 0.0% | 0.0% | 5.1% | 0.0% | 0.0% | 0.0% | 3.4% | 3.4% | 3.4% | 3.4% | |||||||||||||
|
| 0.0% | 0.0% | 5.1% | 1.7% | 0.0% | 1.7% | 3.4% | 10.2% | 8.5% | 3.4% | |||||||||||||